181 related articles for article (PubMed ID: 17013990)
1. ICOS cooperates with CD28, IL-2, and IFN-gamma and modulates activation of human naïve CD4+ T cells.
Mesturini R; Nicola S; Chiocchetti A; Bernardone IS; Castelli L; Bensi T; Ferretti M; Comi C; Dong C; Rojo JM; Yagi J; Dianzani U
Eur J Immunol; 2006 Oct; 36(10):2601-12. PubMed ID: 17013990
[TBL] [Abstract][Full Text] [Related]
2. Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells.
McAdam AJ; Chang TT; Lumelsky AE; Greenfield EA; Boussiotis VA; Duke-Cohan JS; Chernova T; Malenkovich N; Jabs C; Kuchroo VK; Ling V; Collins M; Sharpe AH; Freeman GJ
J Immunol; 2000 Nov; 165(9):5035-40. PubMed ID: 11046032
[TBL] [Abstract][Full Text] [Related]
3. The inducible costimulator (ICOS) is critical for the development of human T(H)17 cells.
Paulos CM; Carpenito C; Plesa G; Suhoski MM; Varela-Rohena A; Golovina TN; Carroll RG; Riley JL; June CH
Sci Transl Med; 2010 Oct; 2(55):55ra78. PubMed ID: 20980695
[TBL] [Abstract][Full Text] [Related]
4. Regulatory roles of IL-2 and IL-4 in H4/inducible costimulator expression on activated CD4+ T cells during Th cell development.
Yagi J; Arimura Y; Dianzani U; Uede T; Okamoto T; Uchiyama T
J Immunol; 2003 Jul; 171(2):783-94. PubMed ID: 12847246
[TBL] [Abstract][Full Text] [Related]
5. CD28 and inducible costimulator (ICOS) signalling can sustain CD154 expression on activated T cells.
Kaminski DA; Lee BO; Eaton SM; Haynes L; Randall TD
Immunology; 2009 Jul; 127(3):373-85. PubMed ID: 19191918
[TBL] [Abstract][Full Text] [Related]
6. ICOS and CD28 reversely regulate IL-10 on re-activation of human effector T cells with mature dendritic cells.
Witsch EJ; Peiser M; Hutloff A; Büchner K; Dorner BG; Jonuleit H; Mages HW; Kroczek RA
Eur J Immunol; 2002 Sep; 32(9):2680-6. PubMed ID: 12207353
[TBL] [Abstract][Full Text] [Related]
7. CD28 and inducible costimulatory protein Src homology 2 binding domains show distinct regulation of phosphatidylinositol 3-kinase, Bcl-xL, and IL-2 expression in primary human CD4 T lymphocytes.
Parry RV; Rumbley CA; Vandenberghe LH; June CH; Riley JL
J Immunol; 2003 Jul; 171(1):166-74. PubMed ID: 12816995
[TBL] [Abstract][Full Text] [Related]
8. CD28 controls differentiation of regulatory T cells from naive CD4 T cells.
Guo F; Iclozan C; Suh WK; Anasetti C; Yu XZ
J Immunol; 2008 Aug; 181(4):2285-91. PubMed ID: 18684917
[TBL] [Abstract][Full Text] [Related]
9. A co-stimulatory molecule on activated T cells, H4/ICOS, delivers specific signals in T(h) cells and regulates their responses.
Arimura Y; Kato H; Dianzani U; Okamoto T; Kamekura S; Buonfiglio D; Miyoshi-Akiyama T; Uchiyama T; Yagi J
Int Immunol; 2002 Jun; 14(6):555-66. PubMed ID: 12039907
[TBL] [Abstract][Full Text] [Related]
10. PI3-kinase and MAP-kinase signaling cascades in AILIM/ICOS- and CD28-costimulated T-cells have distinct functions between cell proliferation and IL-10 production.
Okamoto N; Tezuka K; Kato M; Abe R; Tsuji T
Biochem Biophys Res Commun; 2003 Oct; 310(3):691-702. PubMed ID: 14550257
[TBL] [Abstract][Full Text] [Related]
11. Eminent role of ICOS costimulation for T cells interacting with plasmacytoid dendritic cells.
Janke M; Witsch EJ; Mages HW; Hutloff A; Kroczek RA
Immunology; 2006 Jul; 118(3):353-60. PubMed ID: 16827896
[TBL] [Abstract][Full Text] [Related]
12. Roles of CD28, CTLA4, and inducible costimulator in acute graft-versus-host disease in mice.
Li J; Semple K; Suh WK; Liu C; Chen F; Blazar BR; Yu XZ
Biol Blood Marrow Transplant; 2011 Jul; 17(7):962-9. PubMed ID: 21447398
[TBL] [Abstract][Full Text] [Related]
13. ICOS
Nagase H; Takeoka T; Urakawa S; Morimoto-Okazawa A; Kawashima A; Iwahori K; Takiguchi S; Nishikawa H; Sato E; Sakaguchi S; Mori M; Doki Y; Wada H
Int J Cancer; 2017 Feb; 140(3):686-695. PubMed ID: 27756099
[TBL] [Abstract][Full Text] [Related]
14. Effect of interleukin-15 on anti-CD3/anti-CD28 induced apoptosis of umbilical cord blood CD4+ T cells.
Lin SJ; Yu JC; Cheng PJ; Hsiao SS; Kuo ML
Eur J Haematol; 2003 Dec; 71(6):425-32. PubMed ID: 14703692
[TBL] [Abstract][Full Text] [Related]
15. ICOS costimulation requires IL-2 and can be prevented by CTLA-4 engagement.
Riley JL; Blair PJ; Musser JT; Abe R; Tezuka K; Tsuji T; June CH
J Immunol; 2001 Apr; 166(8):4943-8. PubMed ID: 11290772
[TBL] [Abstract][Full Text] [Related]
16. Selective induction of interleukin-4- and interferon-y-producing T cells from cord blood naive T cells. Effects of costimulatory signaling through CD28.
Katamura K; Tabata Y; Oshima Y; Shintaku N; Yamauchi Y; Mayumi M
Int Arch Allergy Immunol; 1995 Feb; 106(2):101-6. PubMed ID: 7819736
[TBL] [Abstract][Full Text] [Related]
17. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
[TBL] [Abstract][Full Text] [Related]
18. Stimulation via the CD3 and CD28 molecules induces responsiveness to IL-4 in CD4+CD29+CD45R- memory T lymphocytes.
Damle NK; Doyle LV
J Immunol; 1989 Sep; 143(6):1761-7. PubMed ID: 2570801
[TBL] [Abstract][Full Text] [Related]
19. The CD28 related molecule ICOS: T cell modulation in the presence and absence of B7.1/2 and regulational expression in multiple sclerosis.
Wiendl H; Neuhaus O; Mehling M; Wintterle S; Schreiner B; Mitsdoerffer M; Wienhold W; Weissert R; Wessels J; Hartung HP; Weller M; Tolosa E; Melms A
J Neuroimmunol; 2003 Jul; 140(1-2):177-87. PubMed ID: 12864987
[TBL] [Abstract][Full Text] [Related]
20. Synergy between CD28 and CD9 costimulation for naive T-cell activation.
Toyo-oka K; Tai XG; Yashiro Y; Ahn HJ; Abe R; Hamaoka T; Kobayashi M; Neben S; Fujiwara H
Immunol Lett; 1997 Jun; 58(1):19-23. PubMed ID: 9436464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
